# Capricor Therapeutics, Inc.: Form 8-K, filed Oct 9, 2024

- Company: [Capricor Therapeutics, Inc.](/companies/capr.md) (CIK 1133869)
- Form: 8-K
- Filed: 2024-10-09
- Accepted by EDGAR: Oct 9, 2024, 13:16 ET
- Period: 2024-10-09
- Accession: 0001558370-24-013207
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1133869/000155837024013207/capr-20241009x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1133869/000155837024013207/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1133869/000155837024013207/capr-20241009x8k.htm

Filed Oct 9, 2024.
Source: SEC EDGAR, the filing index for accession 0001558370-24-013207. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.